[Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
Nauck
M A
MA
Diabeteszentrum Bad Lauterberg. M.Nauck@Diabeteszentrum.de
Matthaei
S
S
D020909:Acarbose / Q000008:administration & dosage; D000284:Administration, Oral; D003327:Coronary Disease / Q000150:complications* / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D019157:Ischemic Preconditioning, Myocardial; D008687:Metformin / Q000008:administration & dosage; D013453:Sulfonylurea Compounds / Q000008:administration & dosage; D013607:Tablets; D045162:Thiazolidinediones / Q000008:administration & dosage
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D013607:Tablets; D045162:Thiazolidinediones; D008687:Metformin; D020909:Acarbose